DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Miskowiak KW, Ehrenreich H, Christensen EM. et al.
Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: A double-blind, randomized, placebo-controlled phase 2 trial.
J Clin Psychiatry. 2014;
75: 1347-1355
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.